ASCEND BY NTHRYS
Research Abroad Products

Molecular Diagnostics Project Topics

Browse all focused areas across all project categories under this field.

Showing 73–84 of 200 project topics
Minimal Residual Disease Monitoring Real-time Platform
A proprietary software platform that tracks MRD levels through digital PCR and next-generation sequencing with real-time dashboard analytics for oncology clinics. Delivers recurring revenue through monthly subscriptions, institutional licensing, and integration fees with electronic health record systems.
Liquid Biopsy Molecular Diagnostic Platforms Click to view more details →
Cell-Free Fetal DNA Prenatal Screening Commercial Kit
A fully automated diagnostic kit and analysis platform for non-invasive prenatal testing using cfDNA from maternal blood with AI-powered interpretation. Captures market share through direct-to-consumer channels, healthcare provider partnerships, and international distribution networks with high-margin test pricing.
Liquid Biopsy Molecular Diagnostic Platforms Click to view more details →
Pathogen Detection Multiplex qPCR Platform Tool
An integrated hardware and software solution that rapidly identifies infectious pathogens from blood samples using multiplexed quantitative PCR with automated result reporting. Generates B2B revenue through instrument leasing, reagent consumables, and cloud-based laboratory information management services.
Liquid Biopsy Molecular Diagnostic Platforms Click to view more details →
Liquid Biopsy Data Management and Analytics SaaS
An enterprise software platform that consolidates, normalizes, and interprets multi-modal liquid biopsy data from various instruments and assays into clinical reports. Monetizes through per-facility licensing fees, data storage charges, API access tiers, and white-label customization services.
Liquid Biopsy Molecular Diagnostic Platforms Click to view more details →
Immunotherapy Response Prediction Biomarker Testing Service
A molecular diagnostic service that measures circulating immune biomarkers and tumor genomics from liquid biopsies to predict immunotherapy efficacy before treatment initiation. Establishes revenue through companion diagnostic partnerships with pharmaceutical companies and tiered pricing models for precision oncology programs.
Liquid Biopsy Molecular Diagnostic Platforms Click to view more details →
Multi-Cancer Early Detection Blood Test Commercial Assay
A comprehensive liquid biopsy assay that simultaneously detects DNA and protein signals for multiple cancer types from a single blood draw with machine-learning risk stratification. Scales revenue through direct healthcare provider partnerships, insurance reimbursement claims, and potential consumer health screening programs.
Liquid Biopsy Molecular Diagnostic Platforms Click to view more details →
Organ-Specific Cell-Free DNA Fragment Analysis Platform
A specialized diagnostic platform that uses cfDNA fragment size patterns and tissue-of-origin algorithms to detect organ injury, transplant rejection, or early disease from blood. Drives revenue through clinical laboratory partnerships, hospital system integration, and specialty organ transplant monitoring programs.
Liquid Biopsy Molecular Diagnostic Platforms Click to view more details →
Antimicrobial Resistance Gene Detection Rapid Assay Tool
A rapid molecular diagnostic tool that identifies drug-resistance genes in circulating bacterial DNA within hours to guide treatment decisions in sepsis and infection management. Creates revenue through point-of-care device sales, hospital laboratory contracts, and antimicrobial stewardship software integration licensing.
Liquid Biopsy Molecular Diagnostic Platforms Click to view more details →
Real-time CYP450 Genotyping SaaS Platform
A cloud-based software platform that delivers rapid CYP450 enzyme profiling results with automated phenotype prediction integrated into electronic health records. This enables pharmacies and clinics to monetize medication optimization services while reducing adverse drug events by 40-60%.
Pharmacogenomics Molecular Diagnostic Platforms Click to view more details →
Multi-Gene Panel Testing with Clinical Decision Support
A comprehensive molecular diagnostic tool analyzing 50+ pharmacogenes simultaneously with AI-powered clinical recommendation engine for personalized medication dosing. Laboratories and health systems generate recurring revenue through CPT code billing while improving patient outcomes across multiple therapeutic areas.
Pharmacogenomics Molecular Diagnostic Platforms Click to view more details →
Point-of-Care Pharmacogenomics Testing Device Platform
A rapid, portable molecular diagnostic device delivering pharmacogenomic results in under 30 minutes directly at pharmacy or clinic locations without lab infrastructure. This captures high-margin point-of-care testing revenue while enabling same-day prescription optimization and improving medication adherence.
Pharmacogenomics Molecular Diagnostic Platforms Click to view more details →
Integrated Pharmacogenomics Data Analytics and Reporting
An enterprise-grade analytics platform that aggregates pharmacogenomic test results with medication histories and clinical outcomes to generate actionable insights and evidence. Diagnostic companies and payers monetize this through subscription licensing while optimizing medication regimens across patient populations.
Pharmacogenomics Molecular Diagnostic Platforms Click to view more details →